Activelle Minor 0.5 mg - 0.1 mg film-coat. tabl. Belġju - Ingliż - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

activelle minor 0.5 mg - 0.1 mg film-coat. tabl.

novo nordisk pharma sa-nv - estradiol hemihydrate 0,517 mg - eq. estradiol 0,5 mg; norethisterone acetate 0,1 mg - film-coated tablet - 0,5 mg - 0,1 mg - estradiol hemihydrate 0.517 mg; norethisterone acetate 0.1 mg - norethisterone and estrogen

Kliogest Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

kliogest

novo nordisk pharmaceuticals pty ltd - oestradiol hemihydrate; norethisterone acetate; oestradiol -

Kliovance Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

kliovance

novo nordisk pharmaceuticals pty ltd - norethisterone acetate; oestradiol hemihydrate; oestradiol -

Activelle 1 mg/0.5 mg film-coated tablets Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

activelle 1 mg/0.5 mg film-coated tablets

pco manufacturing ltd. - estradiol; norethisterone acetate - film-coated tablet - 1 mg/0.5 milligram(s) - norethisterone and estrogen

Novofem Namibja - Ingliż - Namibia Medicines Regulatory Council

novofem

novo nordisk (pty) ltd - estradiol hemihydrate, norethisterone acetate - tablet - each white tablet contains estradiol hemihydrate equiv. to estradiol 1,0 mg, norethisterone acetate 1,0 mg. each red tablet cont

Kliovance New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

kliovance

novo nordisk pharmaceuticals ltd - estradiol hemihydrate 1.03mg equivalent to 1 mg oestradiol;  ;  ;  ; norethisterone acetate 0.5mg;  ;  ;   - film coated tablet - active: estradiol hemihydrate 1.03mg equivalent to 1 mg oestradiol       norethisterone acetate 0.5mg       excipient: copovidone hypromellose lactose monohydrate magnesium stearate maize starch purified talc triacetin

NOVOFEM Iżrael - Ingliż - Ministry of Health

novofem

novo nordisk ltd., israel - estradiol as hemihydrate; norethisterone acetate - film coated tablets - estradiol as hemihydrate 1 mg; norethisterone acetate 1 mg - estradiol, combinations - estradiol, combinations - hormone replacement therapy (hrt) for estrogen deficiency symptoms in postmenopausal women with an intact uterus. prevention of osteoporosis in postmenopausal women at high risk of future fractures, who are tolerant of , or contraindicated for other medicinal products approved for the prevention of osteoporosis.the experience treating women older than 65 years is limited.

EVIANA Iżrael - Ingliż - Ministry of Health

eviana

novo nordisk ltd., israel - estradiol as hemihydrate; norethisterone acetate - film coated tablets - estradiol as hemihydrate 0.5 mg; norethisterone acetate 0.1 mg - estradiol, combinations - estradiol, combinations - eviana is indicated for women who have a uterus for the: treatment of moderate to severe vasomotor symptoms associated with menopause. prevention of postmenopausal osteoporosis. when prescribing solely for the prevention of postmenopausal osteoporosis therapy should only be considered for women at significant risk of osteoporosis and non-estrogen medications should be carefully considered .the experience treating women older than 65 years is limited .

Kliogest 2 mg/1 mg film-coated tablets Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

kliogest 2 mg/1 mg film-coated tablets

novo nordisk a/s - estradiol; norethisterone acetate - film-coated tablet - 2 mg/1 milligram(s) - progestogens and estrogens, fixed combinations; norethisterone and estrogen

Ryeqo Unjoni Ewropea - Ingliż - EMA (European Medicines Agency)

ryeqo

gedeon richter plc. - relugolix, norethisterone acetate, estradiol hemihydrate - leiomyoma - pituitary and hypothalamic hormones and analogues - ryeqo is indicated in adult women of reproductive age for:- treatment of moderate to severe symptoms of uterine fibroids,- symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis.